Relay Medical Corp.

Recent News

  • Relay Medical: Glow LifeTech Receives Conditional Approval to List on the Canadian Securities Exchange

    Toronto, Ontario--(Newsfile Corp. - November 25, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to report that Glow LifeTech Ltd. ("Glow"), a private company in which Relay currently holds a 21% equity interest, has received conditional approval to list its common shares on the Canadian Securities Exchange ("CSE") pursuant to an amalgamation transaction with Ateba Resources Inc. ("Ateba") (see Ateba's press release dated June 24, 2020).Glow's...

    2020-11-25 9:11 AM ET
  • Relay Medical & Fio Announce Pilot for COVID-19 Rapid Testing with Lonestar Life Sciences at Rural Hospitals in Texas

    Toronto, Ontario--(Newsfile Corp. - November 23, 2020) - Relay Medical Corp.  (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), and Fio Corporation ("Fio"), together Fionet Rapid Response Group ("FRR") are pleased to announce the signing of an MOU with Lonestar Life Sciences on November 19, 2020 to bring COVID-19 rapid diagnostic testing to rural hospitals in Texas.The engagement with Lonestar Life Sciences (LS), targets 10 rural hospitals surrounding the Austin, TX area. At each hospital, the Fionet...

    2020-11-23 3:00 AM ET
  • Relay Medical & Fio to Bring Fionet Mobile COVID-19 Testing & Tracking Platform to Private School Campus and Hockey Rink in the Greater Toronto Area

    Toronto, Ontario--(Newsfile Corp. - November 18, 2020) -  Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company") and Fio Corporation ("Fio"), together Fionet Rapid Response Group ("FRR"), report on an agreement with King Heights Academy and Paramount Ice in the Greater Toronto Area to bring the Fionet COVID-19 mobile testing and tracking platform to their facilities for pilot deployments.King Heights Academy has engaged FRR to assist in providing technologies, services and protocols for safer attendance and...

    2020-11-18 5:01 PM ET
  • Relay Medical Announces Extension of Warrant Expiry Dates

    Toronto, Ontario--(Newsfile Corp. - November 5, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, announces that it intends to extend the expiry date of an aggregate of 7,662,500 previously issued warrants on May 17, 2019 (the "May Warrants") at an exercise price of $0.30 for an additional ninety (90) days, being February 15, 2021. In addition, the Company announces that it intends to extend the expiry date...

    2020-11-05 3:38 PM ET
  • Relay Medical Forms Clinical and Strategic Advisory Boards

    Toronto, Ontario--(Newsfile Corp. - September 22, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company") , a developer of MedTech innovation, is pleased to report on the formation of a Clinical Advisory Board of multi-disciplined experts and a Strategic Advisory Board to guide the Company on regulation, finance, and commercial strategies in the healthtech sector. The Company is also pleased to announce initial appointments to both boards consisting of accomplished medical professionals, senior executives,...

    2020-09-22 1:50 AM ET
  • Relay Medical Announces Closing of Private Placement for Gross Proceeds of Over $1,800,000

    Toronto, Ontario--(Newsfile Corp. - September 17, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), is pleased to announce the closing of a non-brokered private placement financing (the "Offering") of gross proceeds of $1,833,316.02 through the issuance of 10,185,089 units (each, a "Unit") at a price of $0.18 per Unit. Each Unit is comprised of: (i) one common share in the capital of the Company (each a "Common Share"); (ii) one Common...

    2020-09-17 4:18 PM ET
  • Relay Medical and Fio Corporation Announce Joint Venture for Pandemic Testing Technology

    Toronto, Ontario--(Newsfile Corp. - August 19, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), and Fio Corporation ("Fio") are pleased to announce the establishment of a joint venture ("JV") to accelerate adaption and delivery of Fio's proven data-and-device platform, Fionet, as a COVID-19 pandemic testing, data collection and reporting solution. The JV will operate under the name "Fionet Rapid Response Group" and be headquartered in Toronto, Canada. Relay and Fio previously announced...

    2020-08-19 2:00 AM ET
  • Relay Medical and Fio Corporation Extend MOU Agreement for Collaboration on a Rapid Diagnostic Testing Platform

    Toronto, Ontario--(Newsfile Corp. - August 16, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), and Fio Corporation ("Fio") jointly report that the Companies have extended the memorandum of understanding ("MOU" or the "Agreement") previously announced on May 15, 2020 and extended on July 19, 2020.The MOU Agreement has been extended for 7 days with an expiry of August 22, 2020.Under the terms of the agreement Relay will provide expertise in medical technology...

    2020-08-16 7:49 PM ET

Next »